What analyst predict for Taro Pharmaceutical NYSE:TARO ?
Taro Pharmaceutical NYSE:TARO headquartered in Hawthorne, New York, United States is reporting their earnings on 05/17/2018 before the bell. Street forecast for the quarter ending March 2018 is $2.22.
According to stock market daily analyst this is Lower then same time previous year. Taro Pharmaceutical, reported EPS for the same quarter last year was $2.05.
Overview of Taro Pharmaceutical NYSE:TARO
Taro Pharmaceutical Industries is a research-based pharmaceutical manufacturer publicly listed in the New York Stock Exchange. The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. The company’s products are mainly sold in the United States, Canada and Israel. The symbol of the company in NYSE is “TARO”.
Taro Pharmaceutical Industries is reported to be on steady growth since 2008. Its revenues have increased from $327 million to an estimated $717 million, and at the same time, its earnings per share have been increasing from $0.76 to an estimated $6.92 during this period.
|% Change from 52 Week Low|
|% Change from 52 Week High|